Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
30 Sep 2014 Is precision medicine coming of age? Personalised medicine
30 Sep 2014 ESMO 2014 Wrap-Up: What should be remembered?
30 Sep 2014 Pathway of the Day: PI3K/AKT/mTOR Pathology/Molecular biology
30 Sep 2014 ESMO 2014 Press Release: Cancer Medicine Becoming Ever More Precise, Practice-Changing Results at ESMO 2014 Show
29 Sep 2014 Phase III trial data suggest potential new treatment strategies for prostate cancer Genitourinary cancers
29 Sep 2014 ESMO 2014: Pazopanib Improves Progression-Free Survival in Phase II Study in Patients with Advanced GIST Sarcomas - Anticancer agents & Biologic therapy
29 Sep 2014 ESMO 2014: Cobimetinib in Combination with Vemurafenib Improves PFS in BRAF-Mutant Unresectable Locally-Advanced or Metastatic Melanoma Personalised medicine - Melanoma - Anticancer agents & Biologic therapy
29 Sep 2014 ESMO 2014: Combination Dabrafenib/Trametinib Improves OS in Comparison with Vemurafenib in Patients With BRAF-Mutation Positive Melanoma Personalised medicine - Melanoma - Anticancer agents & Biologic therapy
29 Sep 2014 ESMO 2014: Results of a Phase III Randomised Study of Nivolumab in Patients with Advanced Melanoma After Prior Anti-CTLA4 Therapy Melanoma - Immuno-oncology
29 Sep 2014 European Medicines Agency Recommends Granting a Marketing Authorisation for Nintedanib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
29 Sep 2014 ESMO 2014 Press Release: PIK3CA Mutations Blunt Benefit of Anti-HER2 Drugs Breast cancer - Translational research - Anticancer agents & Biologic therapy
29 Sep 2014 ESMO 2014: Results From the CALGB/SWOG 80405 and FIRE-3 (AIO KRK-0306) Studies In All RAS Wild Type Population Gastrointestinal cancers - Anticancer agents & Biologic therapy
29 Sep 2014 Liquid biopsies: Tumour diagnosis and treatment monitoring in a blood test Translational research - Basic science
29 Sep 2014 ESMO 2014 Press Release: RAS Testing Only the First Step for Choosing Treatment for Metastatic Colorectal Cancer, Important New Data Show Gastrointestinal cancers
29 Sep 2014 ESMO 2014: Targeted Treatments for Subsets of NSCLC Patients With Folate-Receptor-Positive, BRAF V600E-Mutant, and With Tumours Carrying HER2 Somatic Mutations Lung and other thoracic tumours - Anticancer agents & Biologic therapy